Alzheimer's Disease and Dementia
Aducanumab, Lecanemab for Early AD: The Clinical Trials That Led to FDA Approval
- GFAP and NfL Are Robust Dementia Markers When Considering Hypercholesterolemia
- Mild Infection Tied to Better Long COVID Symptom Resolve in Younger Patients
- IV Ketamine in Treatment-Resistant BD Shows Real-World Efficacy
- COVID-19 With Opioid, Cocaine Use Increases Endocarditis Risk
- Childhood Maltreatment Is Partial Causal Factor for Later Mental Health Problems
- Nearly Half of People With Dementia Experience a Fall Annually
- Negative Fecal Tests Tied to Low Risk for Advanced Colorectal Cancer
- Persistent Gaps Exist in Continuity of Medication Use for Adults With Diabetes
- Adults With Chronic Pain Replace Opioids With Medical Cannabis for Pain Relief
- How Common Is Migraine With Aura Among Patients Undergoing Sclerotherapy?
- FDA Greenlights Ibuprofen Oral Suspension Compounding to Help With Hospital Supply
- Schizophrenia and Napping Frequency Have Bidirectional Genetic Relationship
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
Buprenorphine Extended-Release SC Injection Under Review Again for Opioid Use Disorder
Diclofenac Epolamine Topical System, a Generic of Flector, Now Available
Discontinuing Long-Term Opioids Tied to Overdose Risk
Recognizing Radiation Therapy as Both Cause and Treatment for Cancer Pain
Oncologists May Lack Understanding of Biosimilars but Use Them Anyway, Survey Suggests
